Adashi E Y, Resnick C E, Hernandez E R, Svoboda M E, Van Wyk J J
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201.
Endocrinology. 1988 Jan;122(1):194-201. doi: 10.1210/endo-122-1-194.
The ovarian granulosa cell has recently been found to be a site of somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) production, reception, and action, thereby raising the prospect of a novel autocrine control mechanism concerned with granulosa cell ontogeny. It is the objective of the in vitro studies reported herein to explore the characteristics of the murine granulosa cell membrane Sm-C/IGF-I receptor and its regulation by gonadotropic, lactogenic, and beta 2-adrenergic signalling. Provision of FSH (150 ng/ml) to granulosa cells from immature rats cultured for 72 h under serum-free conditions resulted in a 3.1-fold increase over control values in specific cell-bound [125I]iodo-Sm-C/IGF-I. Binding to FSH-primed cells proved time, temperature, and pH dependent; optimal steady state conditions were achieved after an 8-h incubation at 15 C and a pH of 8.0. Although subject to regulation by the cellular density of plating, the binding of [125I]iodo-Sm-C/IGF-I to its receptor proved saturable (apparent Kd = 3.3 X 10(-9) M) as well as reversible; complete or partial tracer displacement was effected by competitive inhibition and dilution, respectively. Specificity studies revealed the competition for [125I]iodo-Sm-C/IGF-I binding to follow a relative rank order of potency of Sm-C/IGF-I much greater than multiplication-stimulating activity greater than insulin, but disclosed limited or no displacement by a series of chemically related and unrelated polypeptides. By Scatchard and Hill analysis, both control and FSH-treated cells displayed a single class of noninteracting binding sites; the FSH-enhanced binding represented largely increased binding capacity, rather than affinity. Significantly, up-regulation of granulosa cell Sm-C/IGF-I binding was not limited to FSH; qualitatively comparable increments in [125I]iodo-Sm-C/IGF-I binding were obtained after treatment with luteotropic, and beta 2-adrenergic (but not lactogenic) granulosa cell agonists. Taken together, these studies provide further evidence for the existence of high affinity, low capacity, specific cell membrane receptors for Sm-C/IGF-I in cultured rat granulosa cells. Our findings further indicate that the ability of FSH to enhance granulosa cell Sm-C/IGF-I binding largely reflects increased binding capacity rather than affinity and that this heterologous up-regulatory phenomenon may not be limited to FSH. As such, our observations of comparable up-regulation after luteotropic and beta 2-adrenergic (but not lactogenic) stimulation are in keeping with the view that cAMP may play an intermediary role in the regulation of granulosa cell type I IGF receptors.
最近发现卵巢颗粒细胞是生长调节素-C/胰岛素样生长因子I(Sm-C/IGF-I)产生、接收和发挥作用的场所,从而提出了一种与颗粒细胞个体发育有关的新型自分泌控制机制的可能性。本文报道的体外研究的目的是探索小鼠颗粒细胞膜Sm-C/IGF-I受体的特性及其受促性腺激素、催乳素和β2-肾上腺素能信号的调节。在无血清条件下培养72小时的未成熟大鼠的颗粒细胞中加入促卵泡激素(FSH,150 ng/ml),导致特异性细胞结合的[125I]碘代-Sm-C/IGF-I比对照值增加3.1倍。与FSH预处理细胞的结合证明是时间、温度和pH依赖性的;在15℃和pH 8.0下孵育8小时后达到最佳稳态条件。尽管受接种细胞密度的调节,但[125I]碘代-Sm-C/IGF-I与其受体的结合证明是可饱和的(表观解离常数Kd = 3.3×10-9 M)且可逆;完全或部分示踪剂置换分别通过竞争性抑制和稀释实现。特异性研究表明,[125I]碘代-Sm-C/IGF-I结合的竞争遵循Sm-C/IGF-I的相对效价顺序,远大于促增殖活性大于胰岛素,但一系列化学相关和不相关的多肽显示出有限或无置换作用。通过Scatchard和Hill分析,对照细胞和FSH处理的细胞均显示出一类非相互作用的结合位点;FSH增强的结合主要代表结合能力的增加,而不是亲和力。重要的是,颗粒细胞Sm-C/IGF-I结合的上调不仅限于FSH;用促黄体生成素和β2-肾上腺素能(但不是催乳素)颗粒细胞激动剂处理后,[125I]碘代-Sm-C/IGF-I结合有定性可比的增加。综上所述,这些研究为培养的大鼠颗粒细胞中存在Sm-C/IGF-I的高亲和力、低容量、特异性细胞膜受体提供了进一步的证据。我们的研究结果进一步表明,FSH增强颗粒细胞Sm-C/IGF-I结合的能力主要反映结合能力的增加而不是亲和力,并且这种异源上调现象可能不仅限于FSH。因此,我们观察到促黄体生成素和β2-肾上腺素能(但不是催乳素)刺激后有可比的上调,这与cAMP可能在颗粒细胞I型IGF受体调节中起中介作用的观点一致。